These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31799370)

  • 21. Prevalence and Clinical Correlates of Extended Mechanical Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention in Current Clinical Practice: Insights from the cVAD Registry.
    Davila CD; Sharma S; Krishnamoorthy P; Rengifo-Moreno P; Palacios IF; O'Neill W; Kapur NK; Witzke CF
    Cardiovasc Revasc Med; 2020 Mar; 21(3):342-347. PubMed ID: 31227392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roadmap towards an institutional Impella programme for high-risk coronary interventions.
    Pietrasik A; Gąsecka A; Jasińska-Gniadzik K; Szwed P; Grygier M; Pawłowski T; Sacha J; Kochman J
    ESC Heart Fail; 2023 Aug; 10(4):2200-2213. PubMed ID: 37345215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI.
    Samol A; Wiemer M; Kaese S
    Int J Cardiol; 2022 Aug; 360():7-12. PubMed ID: 35597491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplasty.
    Cubeddu RJ; Don CW; Horvath SA; Gupta PP; Cruz-Gonzalez I; Witzke C; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):782-8. PubMed ID: 22511584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Kuno T; Takagi H; Ando T; Kodaira M; Numasawa Y; Fox J; Bangalore S
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):E636-E645. PubMed ID: 32894797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Vis MM; Koch KT; Paulus WJ; de Mol BA; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):187-94. PubMed ID: 19941329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.
    Amin AP; Spertus JA; Curtis JP; Desai N; Masoudi FA; Bach RG; McNeely C; Al-Badarin F; House JA; Kulkarni H; Rao SV
    Circulation; 2020 Jan; 141(4):273-284. PubMed ID: 31735078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Leistner DM; Dietrich S; Erbay A; Steiner J; Abdelwahed Y; Siegrist PT; Schindler M; Skurk C; Haghikia A; Sinning D; Riedel M; Landmesser U; Stähli BE
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E439-E446. PubMed ID: 32141669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular support during complex transradial percutaneous coronary intervention for complete revascularization.
    Dachille A; Focaccio A; Selvetella L; Napolitano G; Briguori C
    Minerva Cardioangiol; 2019 Aug; 67(4):348-355. PubMed ID: 29527864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R; Pawlik A; Rzeszutko Ł; Bartuś K; Bartuś S
    Kardiol Pol; 2022; 80(12):1224-1231. PubMed ID: 36047958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Planer D; Mehran R; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Reyes SL; Stone GW
    Am J Cardiol; 2011 Oct; 108(8):1068-74. PubMed ID: 21798494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Risk "Protected" Percutaneous Coronary Intervention with Mechanical Circulatory Support in a Non-Surgical Center - An Early Asian Experience.
    Li KFC; Ho HH; Jafary FH; Ong PJL
    Acta Cardiol Sin; 2020 Nov; 36(6):675-680. PubMed ID: 33235425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
    O'Neill WW; Schreiber T; Wohns DH; Rihal C; Naidu SS; Civitello AB; Dixon SR; Massaro JM; Maini B; Ohman EM
    J Interv Cardiol; 2014 Feb; 27(1):1-11. PubMed ID: 24329756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series.
    Bhat RA; Ali SM; Rathi A; Bhat JA; Iqbal RS; Islam MM; Maqbool S; Tibrewal A; Qu Y; Zhang Y; Sun Y; Xiao W; Gao C
    Perfusion; 2023 Jan; 38(1):208-213. PubMed ID: 34581607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.